Skip to content
by Legal Desire
5 August 2024

Latham Advises L’Oréal on Acquisition of Minority Stake in Galderma

Advising firms

Deal team

13 lawyers named
LawyerFirmSeniorityPracticeOffice
Pierre-Louis Cléro Lead Latham & Watkins LLP Partner corporate Paris
Thomas Margenet-Baudry Latham & Watkins LLP Partner Not stated Not stated
Raphaël Darmon Latham & Watkins LLP Counsel Not stated Not stated
Pauline Le Faou Latham & Watkins LLP Associate Not stated Not stated
Mya Lemseffer Latham & Watkins LLP Associate Not stated Not stated
Kenza Driss Latham & Watkins LLP Associate Not stated Not stated
Jacques-Philippe Gunther Latham & Watkins LLP Partner antitrust Paris
Julien Morize Latham & Watkins LLP Associate antitrust Not stated
Marion Penloup Latham & Watkins LLP Associate antitrust Not stated
Jean-Luc Juhan Latham & Watkins LLP Partner IP and commercial contract Paris
Daniel Martel Latham & Watkins LLP Associate IP and commercial contract Not stated
Olivia Rauch-Ravisé Latham & Watkins LLP Partner tax Paris
Camille Pons Latham & Watkins LLP Associate tax Not stated

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
L'OréalBuy-side
Counterparties
Sunshine SwissCo AG (Sell-side)
Abu Dhabi Investment Authority (ADIA) (Sell-side)
Auba Investment Pte. Ltd. (Sell-side)
Galderma Group AG (Target)